Kolexia
Benoit Nicolas Pneumologie
Benoit Nicolas
Pneumologie
Cabinet libéral
Amiens, France
57 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Broncho-pneumopathie chronique obstructive Maladies pulmonaires Paludisme à Plasmodium falciparum Bronchopneumonie Adénocarcinome pulmonaire Métastase tumorale

Collaborateurs

Voir plus
Bethembos-Thielen Stephanie
Bethembos-Thielen Stephanie
Exploration Du Sommeil Picardie -esp, Amiens, France
Carre Olivier
Carre Olivier
Centre Hospitalier de Doullens, Doullens, France
Dayen Charles
Dayen Charles
Ch Saint-quentin, Saint-Quentin, France
Borne-Basler Serge
Borne-Basler Serge
Clinique Victor Pauchet De Butler, Amiens, France

Industries

Voir plus
AstraZeneca
12 collaboration(s)
Dernière en 2023
GSK
10 collaboration(s)
Dernière en 2023
Sanofi
8 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
78P Final analysis of the French real-world study EVIDENS: Effectiveness, safety & quality of life at 36 months of nivolumab in advanced non-small cell lung cancer (NSCLC)
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
Endocavitary Right Ventricular Cardiac Metastasis of a Lung Adenocarcinoma Treated by Surgery: A Case Report About a Novel Multimodal Therapeutic Approach.
Case reports in oncology   14 novembre 2023
EVIDENS: Lung Cancer Patients Treated With Nivolumab: A Longitudinal, Prospective, Observational, Multicentric Study
Essai Clinique (BMS)   18 mai 2022
Impact de la pollution atmosphérique sur les exacerbations de broncho-pneumopathie chronique obstructive dans la Somme : étude BePoPi
26e CONGRÈS DE PNEUMOLOGIE DE LANGUE FRANÇAISE   01 janvier 2022
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.
Lung cancer (Amsterdam, Netherlands)   30 avril 2021
1325P Long-term survival and health-related quality of life in patients treated with nivolumab for advanced non-small cell lung cancer: A wide prospective French real-world study (EVIDENS)
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study.
Oncoimmunology   12 avril 2020
Efficacité et tolérance du nivolumab dans le traitement des patients (pts) atteints de cancer du poumon en France : analyse de survie et de sous-groupes de l’étude de vraie vie EVIDENS
24e Congrès CPLF   01 janvier 2020
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: Updated survival and subgroup analysis from the real-world EVIDENS study
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study
Abstract Book of the European Lung Cancer Congress (ELCC) 10-13 April 2019, Geneva, Switzerland   01 avril 2019